Effect of hypogammaglobulinemia on the incidence of community-acquired respiratory viral infections after lung transplantation

Transplantation Proceedings

Volumn 45, Issue 6, 2013, Pages 2371-2374

  Noell, B C ^a   Dawson, K L ^a   Seethamraju, H ^a  

^a HOUSTON METHODIST HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN G; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; STEROID; TACROLIMUS;

ADENOVIRUS; ADULT; AGED; ARTICLE; COHORT ANALYSIS; COMMUNICABLE DISEASE; DISEASE SEVERITY; FEMALE; FOLLOW UP; FORCED EXPIRATORY VOLUME; GRAFT RECIPIENT; GRAFT REJECTION; HUMAN; HUMAN METAPNEUMOVIRUS; IMMUNOGLOBULIN BLOOD LEVEL; IMMUNOGLOBULIN DEFICIENCY; IMMUNOSUPPRESSIVE TREATMENT; INCIDENCE; INFECTION RISK; INFLUENZA A; INFLUENZA B; LUNG FUNCTION; LUNG TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; MORTALITY; PARAINFLUENZA VIRUS; PRIORITY JOURNAL; RESPIRATORY SYNCYTIAL PNEUMOVIRUS; RHINOVIRUS; SPIROMETRY; TRANSBRONCHIAL BIOPSY; VIRAL RESPIRATORY TRACT INFECTION; VIRUS ISOLATION;

ADULT; AGED; BIOLOGICAL MARKERS; COMMON VARIABLE IMMUNODEFICIENCY; COMMUNITY-ACQUIRED INFECTIONS; FEMALE; FORCED EXPIRATORY VOLUME; GRAFT REJECTION; HUMANS; IMMUNOGLOBULIN G; INCIDENCE; KAPLAN-MEIER ESTIMATE; LUNG; LUNG TRANSPLANTATION; MALE; MIDDLE AGED; RESPIRATORY FUNCTION TESTS; RESPIRATORY TRACT INFECTIONS; RETROSPECTIVE STUDIES; RISK FACTORS; TEXAS; TIME FACTORS; TREATMENT OUTCOME; VIRUS DISEASES;

EID: 84882278604     PISSN: 00411345     EISSN: 18732623     Source Type: Journal    
DOI: 10.1016/j.transproceed.2012.11.010     Document Type: Article

References (20)

1. M.E. Rose, and D.M. Lang Evaluating and managing hypogammaglobulinemia Cleve Clin J Med 73 2 2006 133 144
2. S.J. Pettit, H. Bourne, and G.P. Spickett Survey of infection in patients receiving antibody replacement treatment for immune deficiency J Clin Pathol 55 8 2002 577 580
3. C. Cunningham-Rundles, and C. Bodian Common variable immunodeficiency: Clinical and immunological features of 248 patients Clin Immunol 92 1 1999 34 48
4. M.H. Yamani, R.K. Avery, and S.D. Mawhorter Hypogammaglobulinemia following cardiac transplantation: A link between rejection and infection J Heart Lung Transplant 20 4 2001 425 430
5. E.N. Broeders, K.M. Wissing, and M. Hazzan Evolution of immunoglobulin and mannose binding protein levels after renal transplantation: association with infectious complications Transpl Int 21 1 2008 57 64
6. S. Doron, R. Ruthazer, B.G. Werner, A. Rabson, and D.R. Snydman Hypogammaglobulinemia in liver transplant recipients: Incidence, timing, risk factors, and outcomes Transplantation 81 5 2006 697 703
7. N.S. Goldfarb, R.K. Avery, and M. Goormastic Hypogammaglobulinemia in lung transplant recipients Transplantation 71 2 2001 242 246
8. S.M. Kawut, L. Shah, and J.S. Wilt Risk factors and outcomes of hypogammaglobulinemia after lung transplantation Transplantation 79 12 2005 1723 1726
9. N.H. Yip, D.J. Lederer, and S.M. Kawut Immunoglobulin G levels before and after lung transplantation Am J Respir Crit Care Med 173 8 2006 917 921
10. J.L. Billings, M.I. Hertz, and C.H. Wendt Community respiratory virus infections following lung transplantation Transpl Infect Dis 3 3 2001 138 148
11. S.M. Palmer Jr, N.G. Henshaw, D.N. Howell, S.E. Miller, R.D. Davis, and V.F. Tapson Community respiratory viral infection in adult lung transplant recipients Chest 113 4 1998 944 950
12. M.M. Chakinala, and M.J. Walter Community acquired respiratory viral infections after lung transplantation: clinical features and long-term consequences Semin Thorac Cardiovasc Surg 16 4 2004 342 349
13. D. Kumar, S. Husain, and M.H. Chen A prospective molecular surveillance study evaluating the clinical impact of community-acquired respiratory viruses in lung transplant recipients Transplantation 89 8 2010 1028 41033
14. D. Kumar, D. Erdman, and S. Keshavjee Clinical impact of community-acquired respiratory viruses on bronchiolitis obliterans after lung transplant Am J Transplant 5 8 2005 2031 42036
15. J. Gottlieb, T.F. Schulz, and T. Welte Community-acquired respiratory viral infections in lung transplant recipients: a single season cohort study Transplantation 87 10 2009 1530 41537
16. H. Reichenspurner, R.E. Girgis, and R.C. Robbins Stanford experience with obliterative bronchiolitis after lung and heart-lung transplantation Ann Thorac Surg 62 5 1996 1467 1472 discussion 1472-1473
17. J.L. Todd, and S.M. Palmer Bronchiolitis obliterans syndrome: the final frontier for lung transplantation Chest 140 2 2011 502 508
18. C.A. Finlen Copeland, and L.D. Snyder Survival after bronchiolitis obliterans syndrome among bilateral lung transplant recipients Am J Respir Crit Care Med 182 6 2010 784 789
19. J.D. Christie, L.B. Edwards, and P. Aurora Registry of the international society for heart and lung transplantation: twenty-fifth official adult lung and heart/lung transplantation report - 2008 J Heart Lung Transplant 27 9 2008 957 969
20. A.P. Khalifah, R.R. Hachem, and M.M. Chakinala Respiratory viral infections are a distinct risk for bronchiolitis obliterans syndrome and death Am J Respir Crit Care Med 170 2 2004 181 187